Detalhe da pesquisa
1.
Inhibition of Cdk5 induces cell death of tumor-initiating cells.
Br J Cancer
; 116(7): 912-922, 2017 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222068
2.
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach.
J Hepatol
; 63(1): 102-13, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25660209
3.
Regulation of endothelial signaling and migration by v-ATPase.
Angiogenesis
; 17(3): 587-601, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24254321
4.
Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor.
Circulation
; 124(17): 1848-59, 2011 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21969013
5.
IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors.
Mol Cancer
; 11: 9, 2012 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22401581
6.
Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis.
J Biol Chem
; 285(46): 35932-43, 2010 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20826806
7.
Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases.
Angiogenesis
; 14(3): 281-91, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21487803
8.
Anti-angiogenic potential of small molecular inhibitors of cyclin dependent kinases in vitro.
Angiogenesis
; 13(3): 239-49, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20706783
9.
Ginkgo biloba extract EGb 761 exerts anti-angiogenic effects via activation of tyrosine phosphatases.
J Cell Mol Med
; 13(8B): 2122-2130, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19175691
10.
The novel brassinosteroid analog BR4848 inhibits angiogenesis in human endothelial cells and induces apoptosis in human cancer cells in vitro.
J Steroid Biochem Mol Biol
; 178: 263-271, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307714
11.
Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.
Oncotarget
; 7(19): 27108-21, 2016 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27027353
12.
Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation.
Eur J Med Chem
; 112: 347-366, 2016 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26907157
13.
Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.
Oncotarget
; 7(5): 6088-104, 2016 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755662
14.
Cdk5 and Foxc2--a new relationship in the lymphatic vasculature.
Oncotarget
; 6(26): 21799-801, 2015 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26327394
15.
Anti-leukemic effects of the V-ATPase inhibitor Archazolid A.
Oncotarget
; 6(41): 43508-28, 2015 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26496038
16.
Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer.
Cancer Res
; 75(14): 2863-74, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018087
17.
Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2.
Nat Commun
; 6: 7274, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26027726
18.
In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor.
Cardiovasc Res
; 104(2): 303-14, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25239826
19.
Trisubstituted pyrazolopyrimidines as novel angiogenesis inhibitors.
PLoS One
; 8(1): e54607, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23336010
20.
Indirubin derivative 6BIO suppresses metastasis.
Cancer Res
; 73(19): 6004-12, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23946383